factually
Index/Organizations/liraglutide

liraglutide

Pharmaceutical drug

Fact-Checks

4 results
Jan 18, 2026

How do GLP‑1 and GLP‑1/GIP receptor agonists compare to very low calorie diets in randomized trials measuring drug‑off remission?

Randomized trials show two contrasting pathways to diabetes remission and weight loss: intensive very low calorie diets (VLCDs) can produce drug‑off remission with lasting benefit in protocolized prog...

Jan 13, 2026

What are the head‑to‑head A1C and weight results for semaglutide versus other GLP‑1RAs and SGLT2 inhibitors?

Randomized trials and pooled analyses show semaglutide delivers larger average reductions in HbA1c and body weight than many other GLP‑1 receptor agonists (GLP‑1RAs), with head‑to‑head meta‑analysis f...

Jan 11, 2026

How do GLP‑1 weight‑loss medications differ mechanistically and clinically from appetite‑control food tricks like gelatin?

GLP‑1 receptor agonists are prescription drugs that mimic an endogenous gut hormone to alter brain and gut circuits, slow gastric emptying, improve glycemic control and produce clinically meaningful, ...

Nov 3, 2025

How does Barislend compare to other prescription weight loss medications?

BariSlend is marketed as a dietary supplement claiming to support weight loss through plant-based ingredients, but the available materials show with prescription anti-obesity drugs such as semaglutide...